nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—skin epidermis—psoriasis	0.126	0.427	CbGeAlD
Chloropyramine—PTK2—endothelium—psoriasis	0.0916	0.309	CbGeAlD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—CARD14—psoriasis	0.0643	0.0921	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TNIP1—psoriasis	0.0404	0.0579	CbGpPWpGaD
Chloropyramine—PTK2—skin of body—psoriasis	0.0391	0.132	CbGeAlD
Chloropyramine—PTK2—tendon—psoriasis	0.0298	0.101	CbGeAlD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—MKI67—psoriasis	0.0289	0.0414	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—IVL—psoriasis	0.0266	0.0382	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—CRP—psoriasis	0.0191	0.0273	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—ZMIZ1—psoriasis	0.0176	0.0253	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—TGFA—psoriasis	0.0169	0.0243	CbGpPWpGaD
Chloropyramine—PTK2—MFAP5-mediated ovarian cancer cell motility and invasiveness—JUN—psoriasis	0.0167	0.0239	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—REL—psoriasis	0.0132	0.019	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—CXCL8—psoriasis	0.0124	0.0178	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CARM1—psoriasis	0.0114	0.0163	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—ITGAL—psoriasis	0.0112	0.0161	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—SERPINB8—psoriasis	0.0106	0.0151	CbGpPWpGaD
Chloropyramine—HRH1—tendon—psoriasis	0.00929	0.0314	CbGeAlD
Chloropyramine—PTK2—Overview of nanoparticle effects—TNF—psoriasis	0.00864	0.0124	CbGpPWpGaD
Chloropyramine—PTK2—Angiogenesis—VEGFA—psoriasis	0.00836	0.012	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—psoriasis	0.00822	0.0118	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—ICAM1—psoriasis	0.0075	0.0107	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—NFKBIA—psoriasis	0.00744	0.0107	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—JUN—psoriasis	0.00725	0.0104	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—PCNA—psoriasis	0.00714	0.0102	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—IL6—psoriasis	0.00697	0.00999	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—ITGAL—psoriasis	0.00672	0.00963	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—NFKBIA—psoriasis	0.00659	0.00944	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events regulated by Ret tyrosine kinase—JUN—psoriasis	0.00649	0.0093	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriasis	0.00635	0.0091	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NFKBIA—psoriasis	0.00635	0.0091	CbGpPWpGaD
Chloropyramine—PTK2—EPHA-mediated growth cone collapse—VEGFA—psoriasis	0.00633	0.00907	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—STAT3—psoriasis	0.00627	0.00898	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—LEP—psoriasis	0.00623	0.00892	CbGpPWpGaD
Chloropyramine—Rosiglitazone—PPARG—psoriasis	0.0061	1	CrCbGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—HLA-DRB1—psoriasis	0.00557	0.00797	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—SOCS1—psoriasis	0.0055	0.00787	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.00514	0.00736	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.00512	0.00734	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—JUN—psoriasis	0.005	0.00717	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—JUN—psoriasis	0.00493	0.00706	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.00493	0.00706	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—psoriasis	0.00489	0.007	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—IL4—psoriasis	0.0048	0.00687	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—NFKB1—psoriasis	0.00475	0.0068	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—KIR2DS1—psoriasis	0.00471	0.00675	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00471	0.00675	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—CXCL8—psoriasis	0.0047	0.00673	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by focal adhesion kinase—JUN—psoriasis	0.00454	0.0065	CbGpPWpGaD
Chloropyramine—PTK2—Fc-epsilon receptor I signaling in mast cells—JUN—psoriasis	0.00454	0.0065	CbGpPWpGaD
Chloropyramine—PTK2—Fc-epsilon receptor I signaling in mast cells—NFKB1—psoriasis	0.00437	0.00626	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—JUN—psoriasis	0.00437	0.00626	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—NFKB1—psoriasis	0.0042	0.00602	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—psoriasis	0.00405	0.00581	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.00398	0.00571	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CD4—psoriasis	0.00393	0.00562	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—VEGFA—psoriasis	0.00386	0.00554	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriasis	0.0038	0.00545	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—NFKBIA—psoriasis	0.00378	0.00541	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—PCNA—psoriasis	0.00373	0.00534	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—NFKB1—psoriasis	0.0037	0.00531	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—JUN—psoriasis	0.00365	0.00523	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—DDX58—psoriasis	0.00365	0.00523	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—psoriasis	0.00364	0.00522	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—psoriasis	0.00364	0.00521	CbGpPWpGaD
Chloropyramine—PTK2—Caspase Cascade in Apoptosis—TNF—psoriasis	0.00359	0.00514	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—HCAR2—psoriasis	0.00359	0.00514	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—TYK2—psoriasis	0.00358	0.00512	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—CXCL8—psoriasis	0.00351	0.00503	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—TYK2—psoriasis	0.00338	0.00484	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—JUN—psoriasis	0.00336	0.00481	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—STAT3—psoriasis	0.00333	0.00477	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—TP53—psoriasis	0.0033	0.00473	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—NFKB1—psoriasis	0.00315	0.00451	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—TYK2—psoriasis	0.0031	0.00443	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—ITGAL—psoriasis	0.00307	0.0044	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—STAT3—psoriasis	0.00304	0.00435	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—STAT3—psoriasis	0.0029	0.00416	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CARM1—psoriasis	0.00288	0.00413	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—VEGFA—psoriasis	0.00281	0.00402	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TP53—psoriasis	0.00278	0.00398	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—VEGFA—psoriasis	0.00253	0.00362	CbGpPWpGaD
Chloropyramine—PTK2—NCAM signaling for neurite out-growth—IL6—psoriasis	0.00251	0.0036	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—IFIH1—psoriasis	0.00251	0.0036	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—JUN—psoriasis	0.00245	0.00351	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00245	0.00351	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ERAP1—psoriasis	0.00241	0.00346	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—NFKB1—psoriasis	0.00241	0.00346	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—VEGFA—psoriasis	0.00239	0.00342	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—HLA-C—psoriasis	0.00238	0.00341	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—TNFAIP3—psoriasis	0.00235	0.00337	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—HCAR2—psoriasis	0.00217	0.00311	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—STAT3—psoriasis	0.00217	0.00311	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—DDX58—psoriasis	0.00212	0.00304	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—JUN—psoriasis	0.00208	0.00298	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—HCAR2—psoriasis	0.00203	0.0029	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—HLA-E—psoriasis	0.00198	0.00283	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TAGAP—psoriasis	0.00188	0.0027	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CCL20—psoriasis	0.00186	0.00267	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—HCAR2—psoriasis	0.00184	0.00264	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—JUN—psoriasis	0.00183	0.00262	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—STAT3—psoriasis	0.0018	0.00257	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—IL6—psoriasis	0.00175	0.00251	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—IL6—psoriasis	0.00165	0.00237	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—SOCS1—psoriasis	0.00165	0.00236	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TP53—psoriasis	0.00162	0.00231	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TNF—psoriasis	0.00161	0.00231	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ITGAL—psoriasis	0.00161	0.00231	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—VEGFA—psoriasis	0.0016	0.00229	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—REL—psoriasis	0.00151	0.00216	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—TYK2—psoriasis	0.00147	0.00211	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IFIH1—psoriasis	0.00146	0.00209	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TP53—psoriasis	0.00142	0.00204	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.00142	0.00203	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—HLA-B—psoriasis	0.00141	0.00202	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-C—psoriasis	0.00139	0.00199	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—LEP—psoriasis	0.00138	0.00197	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—TNFAIP3—psoriasis	0.00137	0.00196	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—NOS2—psoriasis	0.00126	0.00181	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CRP—psoriasis	0.00124	0.00178	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—PPARG—psoriasis	0.0012	0.00172	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-E—psoriasis	0.00115	0.00165	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—NFKBIA—psoriasis	0.00113	0.00163	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCL20—psoriasis	0.00113	0.00162	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—HCAR2—psoriasis	0.00109	0.00156	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CCL20—psoriasis	0.00105	0.00151	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—TYK2—psoriasis	0.00105	0.00151	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—VEGFA—psoriasis	0.00104	0.00149	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00102	0.00147	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—SOCS1—psoriasis	0.000961	0.00138	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCL20—psoriasis	0.000956	0.00137	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TAGAP—psoriasis	0.000943	0.00135	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—TYK2—psoriasis	0.000929	0.00133	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD8A—psoriasis	0.000852	0.00122	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CD4—psoriasis	0.00084	0.0012	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—NFKB1—psoriasis	0.00082	0.00117	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-B—psoriasis	0.00082	0.00117	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-A—psoriasis	0.00076	0.00109	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—JUN—psoriasis	0.000752	0.00108	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—VEGFA—psoriasis	0.000744	0.00107	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—STAT3—psoriasis	0.000737	0.00106	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—VEGFA—psoriasis	0.00073	0.00105	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CRP—psoriasis	0.000725	0.00104	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—NFKB1—psoriasis	0.000724	0.00104	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—IL6—psoriasis	0.000721	0.00103	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-DRB1—psoriasis	0.000694	0.000994	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ICAM1—psoriasis	0.000666	0.000954	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000661	0.000947	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—NFKBIA—psoriasis	0.000661	0.000947	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—TNF—psoriasis	0.000638	0.000913	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SOCS1—psoriasis	0.000621	0.00089	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCL20—psoriasis	0.000565	0.000809	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TP53—psoriasis	0.000551	0.00079	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—TYK2—psoriasis	0.000541	0.000775	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—IL6—psoriasis	0.000515	0.000737	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IFNG—psoriasis	0.000507	0.000726	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CXCL8—psoriasis	0.000503	0.000721	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000501	0.000718	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD4—psoriasis	0.000489	0.000701	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—LEP—psoriasis	0.000458	0.000657	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—APOE—psoriasis	0.000458	0.000657	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—IL6—psoriasis	0.000454	0.000651	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—JUN—psoriasis	0.000438	0.000628	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NFKBIA—psoriasis	0.000427	0.000612	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—NFKB1—psoriasis	0.000422	0.000604	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—STAT3—psoriasis	0.000379	0.000543	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TYK2—psoriasis	0.00035	0.000501	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SOCS1—psoriasis	0.000311	0.000446	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CXCL8—psoriasis	0.000305	0.000436	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—TYK2—psoriasis	0.000297	0.000425	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	0.000284	0.000407	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—JUN—psoriasis	0.000283	0.000406	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NFKB1—psoriasis	0.000273	0.000391	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IL6—psoriasis	0.000265	0.000379	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CXCL8—psoriasis	0.000258	0.00037	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—VEGFA—psoriasis	0.000247	0.000354	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—STAT3—psoriasis	0.000245	0.000351	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—APOE—psoriasis	0.00023	0.000329	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—LEP—psoriasis	0.00023	0.000329	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NFKBIA—psoriasis	0.000214	0.000306	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TP53—psoriasis	0.000187	0.000268	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TYK2—psoriasis	0.000175	0.000251	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IL6—psoriasis	0.000171	0.000245	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CXCL8—psoriasis	0.000153	0.000219	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—IL6—psoriasis	0.000145	0.000208	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—JUN—psoriasis	0.000142	0.000203	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NFKB1—psoriasis	0.000137	0.000196	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—VEGFA—psoriasis	0.000124	0.000177	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—STAT3—psoriasis	0.000123	0.000176	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TP53—psoriasis	9.36e-05	0.000134	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IL6—psoriasis	8.57e-05	0.000123	CbGpPWpGaD
